Multitarget Therapeutic Strategies for Chagas Disease: Natural Compounds, Antimicrobial Peptides, and Cell-Based Immunomodulation
Infectious Disease Reports · 30.06.2026 · 18 (4) · 65
DOI: 10.3390/idr18040065 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Infectious Disease Reports, online erschienen am 30.06.2026. Verfasst von Ana María Fernández-Presas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico. Die Arbeit nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Division, Faculty of Medicine, Universidad Nacional Autónoma de México.
Abstract (Originalsprache)
Chagas disease, caused by Trypanosoma cruzi, remains a major public health problem in Latin America and an emerging global health concern due to population mobility. Although benznidazole and nifurtimox remain the only approved antiparasitic drugs, their limited efficacy in chronic infection, prolonged treatment regimens, frequent adverse effects, and variable activity across parasite strains highlight the need for new therapeutic strategies. In addition, the pathogenesis of chronic Chagas disease is driven not only by parasite persistence but also by immune-mediated tissue damage, particularly in chronic Chagas cardiomyopathy. In this review, we examine emerging therapeutic approaches that extend beyond conventional trypanocidal chemotherapy, with emphasis on natural products, antimicrobial peptides, and cell-based immunomodulatory strategies. Plant compounds and essential oils have shown antiparasitic activity through mechanisms including oxidative stress induction, membrane disruption, interference with sterol biosynthesis, and mitochondrial dysfunction, while some extracts also modulate host immune responses. Antimicrobial peptides display dual potential by directly damaging parasite membranes and organelles or by reshaping infection-associated inflammatory responses. In parallel, cell-based therapies such as mesenchymal stromal cells, tolerogenic dendritic cells, and bone marrow-derived cells have demonstrated promising cardioprotective and immunoregulatory effects in experimental chronic Chagas disease. Collectively, these approaches support a multitarget therapeutic framework in which parasite-directed and host-directed interventions may complement each other. Further mechanistic studies, standardization, and translational validation will be essential to advance these candidates toward clinically useful therapies for Chagas disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Parasitology, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Department of Cellular and Tissue Biology, Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Experimental Medicine Research Unit, Faculty of Medicine, Universidad Nacional Autónoma de México, Hospital General de México "Dr. Eduardo Liceaga", Mexico City 06726, Mexico.
ORCID-Profile: Ana María Fernández-Presas, Katia Jarquín-Yáñez, Adolfo Cruz-Reséndiz, Oscar Rodríguez-Lima, Jaime Zamora-Chimal, Blanca Esther Blancas-Luciano
Förderung
- Research Division, Faculty of Medicine, Universidad Nacional Autónoma de México
Zitieren
APA
Fernández-Presas, A. M., Jarquín-Yáñez, K., Cruz-Reséndiz, A., Rodríguez-Lima, O., Zamora-Chimal, J., & Blancas-Luciano, B. E. (2026). Multitarget Therapeutic Strategies for Chagas Disease: Natural Compounds, Antimicrobial Peptides, and Cell-Based Immunomodulation. Infectious Disease Reports, 18(4), 65. https://doi.org/10.3390/idr18040065
Vancouver
Fernández-Presas AM, Jarquín-Yáñez K, Cruz-Reséndiz A, Rodríguez-Lima O, Zamora-Chimal J, Blancas-Luciano BE. Multitarget Therapeutic Strategies for Chagas Disease: Natural Compounds, Antimicrobial Peptides, and Cell-Based Immunomodulation. Infectious Disease Reports. 2026;18(4):65. doi:10.3390/idr18040065
BibTeX
@article{FernndezPresas2026,
author = {Fernández-Presas, Ana María and Jarquín-Yáñez, Katia and Cruz-Reséndiz, Adolfo and Rodríguez-Lima, Oscar and Zamora-Chimal, Jaime and Blancas-Luciano, Blanca Esther},
title = {Multitarget Therapeutic Strategies for Chagas Disease: Natural Compounds, Antimicrobial Peptides, and Cell-Based Immunomodulation},
journal = {Infectious Disease Reports},
year = {2026},
volume = {18},
number = {4},
pages = {65},
doi = {10.3390/idr18040065}
}
EUVIMED